MétaCan
Menu
Back to cohort
Record W2981331525 · doi:10.1093/ofid/ofz360.1668

1988. Impact of a Novel Pharmacist Practice Model on Antimicrobial Usage and Hospital-acquired Clostridium difficile (HACDI) Rates

2019· article· en· W2981331525 on OpenAlexaffabout
Pegah Pourgolafshan, Ivan Ying, Danny Z. Chen

Bibliographic record

VenueOpen Forum Infectious Diseases · 2019
Typearticle
Languageen
FieldImmunology and Microbiology
TopicAntibiotic Use and Resistance
Canadian institutionsYork Central Hospital
Fundersnot available
KeywordsMedicineAntimicrobial stewardshipPharmacistCeftriaxoneAntimicrobialClostridium difficileStaffingAuditIntensive care unitHealth careClinical pharmacyFamily medicineEmergency medicineAntibioticsIntensive care medicineNursingAntibiotic resistancePharmacyMicrobiology

Abstract

fetched live from OpenAlex

Abstract Background The Antimicrobial Stewardship Program (ASP) was implemented at our 425-bed community hospital in June of 2012. The ASP team, 1 pharmacist, and 1 infectious diseases physician reviewed all intensive care patients on antimicrobials as well as patients on select broad-spectrum antibiotics. In 2016, ASP expansion was undertaken without additional staffing using a novel unit pharmacist model. The effectiveness of in-house antimicrobial stewardship (AMS) training programs for unit pharmacists is not well described. We report the impact of our model on antimicrobial usage and HACDI rates. Methods In 2016, an extensive AMS training and certification program was developed for all unit pharmacists. The program consisted of learning modules, didactic lectures, competency assessments, and individual teaching by the ASP team. In 2017, the practice model was rolled out and the ASP team met with each pharmacist biweekly to review prospective audit and feedback cases with a focus on ceftriaxone and fluoroquinolones. Antimicrobial usage was tracked by defined daily doses (DDD) per 1,000 patient-days, as defined by the World Health Organization. HACDI rates per 1,000 patient-days were defined by the Ontario Ministry of Health and Long Term Care. Results Since the model launched in 2017 until March of 2019, total antimicrobial usage was decreased by 22% (P < 0.001), fluoroquinolones by 21% (P = 0.01), and ceftriaxone by 53% (P < 0.001). HACDI rates decreased from 0.30 to 0.16 cases per 1,000 patient-days (47%, P = 0.12) (Figure 1). Since ASP implementation in 2012, total antimicrobial usage has been reduced by 35% (P < 0.01), fluoroquinolones by 73% (P < 0.001), clindamycin by 70% (P = 0.05) and rates of HACDI by 73% (P < 0.0001) (Figure 2). Pseudomonas susceptibility rates improved (2012 vs. 2017) for meropenem (86% to 93%), ciprofloxacin (73% to 90%), and piperacillin–tazobactam (80 to 92%), but did not reach statistical significance. Conclusion To the best of our knowledge, this is the first description in the literature of an in-house AMS training and certification program for unit pharmacists and its impact on clinical outcomes. This novel approach creates a sustainable and staffing neutral practice model that effectively reduces unnecessary antimicrobial usage and HACDI, resulting in improved patient safety. Disclosures All authors: No reported disclosures.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.041

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.013
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.302
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicAntibiotic Use and ResistanceFrench-language works237,207